Pollak M - Search Results

1

A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.

Flaig TW, Glodé M, Gustafson D, van Bokhoven A, Tao Y, Wilson S, Su LJ, Li Y, Harrison G, Agarwal R, Crawford ED, Lucia MS, Pollak M. Flaig TW, et al. Among authors: pollak m. Prostate. 2010 Jun 1;70(8):848-55. doi: 10.1002/pros.21118. Prostate. 2010. PMID: 20127732 Clinical Trial.

2

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Ma J, et al. Among authors: pollak mn. J Natl Cancer Inst. 1999 Apr 7;91(7):620-5. doi: 10.1093/jnci/91.7.620. J Natl Cancer Inst. 1999. PMID: 10203281

3

Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.

Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC, Giovannucci E. Platz EA, et al. Among authors: pollak mn. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1107-10. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10613344

4

A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men.

Ma J, Pollak M, Giovannucci E, Chan JM, Tao Y, Hennekens C, Stampfer MJ. Ma J, et al. Among authors: pollak m. Growth Horm IGF Res. 2000 Apr;10 Suppl A:S28-9. doi: 10.1016/s1096-6374(00)90013-3. Growth Horm IGF Res. 2000. PMID: 10984282 No abstract available.

5

Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.

Zi X, Zhang J, Agarwal R, Pollak M. Zi X, et al. Among authors: pollak m. Cancer Res. 2000 Oct 15;60(20):5617-20. Cancer Res. 2000. PMID: 11059749

6

A prospective study of plasma C-peptide and colorectal cancer risk in men.

Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ. Ma J, et al. Among authors: pollak m. J Natl Cancer Inst. 2004 Apr 7;96(7):546-53. doi: 10.1093/jnci/djh082. J Natl Cancer Inst. 2004. PMID: 15069117

7

Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.

Rollison DE, Newschaffer CJ, Tao Y, Pollak M, Helzlsouer KJ. Rollison DE, et al. Among authors: pollak m. Int J Cancer. 2006 Mar 1;118(5):1279-84. doi: 10.1002/ijc.21471. Int J Cancer. 2006. PMID: 16161053

8

Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis.

Liu B, Lee KW, Anzo M, Zhang B, Zi X, Tao Y, Shiry L, Pollak M, Lin S, Cohen P. Liu B, et al. Among authors: pollak m. Oncogene. 2007 Mar 15;26(12):1811-9. doi: 10.1038/sj.onc.1209977. Epub 2006 Sep 18. Oncogene. 2007. PMID: 16983336

9

Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.

Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R. Singh RP, et al. Carcinogenesis. 2007 Dec;28(12):2567-74. doi: 10.1093/carcin/bgm218. Epub 2007 Oct 4. Carcinogenesis. 2007. PMID: 17916909

10

Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.

Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R. Raina K, et al. Among authors: pollak mn. Cancer Res. 2007 Nov 15;67(22):11083-91. doi: 10.1158/0008-5472.CAN-07-2222. Cancer Res. 2007. PMID: 18006855

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

865 results

Search Page

Filters